LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
468
via finance.yahoo.comBusiness & Companies

3 Reasons to Avoid UTHR and 1 Stock to Buy Instead

FROM THE WIRE · FINANCE.YAHOO.COM

3 Reasons to Avoid UTHR and 1 Stock to Buy Instead Since April 2026, United Therapeutics has been in a holding pattern, posting a small loss of 4.2% while floating around $541.72. The stock also fell short of the S&P 500's 17.5% gain during that period. Is there a buying…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishUnited Therapeutics has underperformed the S&P 500 with weak revenue forecasts per analysts.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01United Therapeutics has posted a 4.2% loss since April 2026, while the S&P 500 gained 17.5%.
  2. 02The stock currently trades at $541.72 per share.
  3. 03Wall Street revenue forecasts signal weak prospects for the company over the next 12 months.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.